← Back to Clinical Trials
Recruiting NCT07478393

NCT07478393 Readiness and Progress in Emotion Regulation Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07478393
Status Recruiting
Phase
Sponsor Teachers College, Columbia University
Condition Rumination
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-10-24
Primary Completion 2028-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Emotion Regulation Therapy via Telehealth

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2025-10-24 with a primary completion date of 2028-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is an open trial designed to examine individual changes that occur before, during, and after 6 modules of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

Eligibility Criteria

Inclusion Criteria: * Between the ages of 18 and 65 * Fluent in English (and therefore able to provide consent) * Currently living in New York State * Access to at least one device with internet and video-conferencing capabilities * High self-reported worry, rumination, and/or self-criticism * Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder Exclusion Criteria: * Active suicidal ideation or intent * Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder * Currently in therapy or receiving any type of psychosocial treatment * Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months * Current students at Teachers College, Columbia University

Contact & Investigator

Central Contact

Douglas S Mennin

✉ mennin@tc.columbia.edu

📞 212.678.6609

Principal Investigator

Douglas S Mennin

PRINCIPAL INVESTIGATOR

Professor of Clinical Psychology

Frequently Asked Questions

Who can join the NCT07478393 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rumination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07478393 currently recruiting?

Yes, NCT07478393 is actively recruiting participants. Contact the research team at mennin@tc.columbia.edu for enrollment information.

Where is the NCT07478393 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07478393 clinical trial?

NCT07478393 is sponsored by Teachers College, Columbia University. The principal investigator is Douglas S Mennin at Professor of Clinical Psychology. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology